ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

ZIPRASIDONUM

Active substance (INN) · ATC N05AE04 · 4 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
N018F	ZIPRASIDONUM	In force	medicine of the protocol	C1-G15	YES

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
ZYPSILA 20 mg	CAPS.	20mg	KRKA, D.D., NOVO MESTO - SLOVENIA	N05AE04	PRF
ZYPSILA 40 mg	CAPS.	40mg	KRKA, D.D., NOVO MESTO - SLOVENIA	N05AE04	PRF
ZYPSILA 60 mg	CAPS.	60mg	KRKA, D.D., NOVO MESTO - SLOVENIA	N05AE04	PRF
ZYPSILA 80 mg	CAPS.	80mg	KRKA, D.D., NOVO MESTO - SLOVENIA	N05AE04	PRF

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.